Charles Geer
Internal Medicine · Charleston, SCNPI 1497782668
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 237 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,187 and has fallen 96.2% since, to $46 in 2025.
Across 237 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$432
- AstraZeneca$346
- Lilly USA, LLC$308
- Amgen$288
- AbbVie$232
- Boehringer Ingelheim$213
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,842100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 31 | $432 |
| AstraZeneca | 23 | $346 |
| Lilly USA, LLC | 19 | $308 |
| Amgen(2 entities) | 20 | $288 |
| AbbVie(2 entities) | 14 | $232 |
| Boehringer Ingelheim | 14 | $213 |
| GSK | 10 | $187 |
| Novartis | 11 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $129 |
| Pfizer | 8 | $128 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $125 |
| Sunovion Pharmaceuticals Inc. | 7 | $125 |
| Supernus Pharmaceuticals, Inc. | 4 | $120 |
| Vanda Pharmaceuticals Inc. | 4 | $113 |
| Johnson & Johnson | 7 | $100 |
| Biohaven Pharmaceuticals, Inc. | 5 | $92 |
| Bayer | 5 | $86 |
| Radius Health, Inc. | 4 | $85 |
| Amarin Pharma, Inc. | 5 | $84 |
| Esperion Therapeutics, Inc. | 5 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Astellas Pharma US Inc | 3 | $52 |
| Merck | 4 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Abbott | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Cequr Corporation | 2 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Phadia US Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $12 |
| Optinose US, Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $11 |
How this compares
$3,842 in reported general payments places this provider in the 85th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Charleston
- Jan BasileCharleston$278K
- John CleekCharleston$136K
- Leonard AlsfeldCharleston$91K
- Brett TomashitisCharleston$36K
- Scott SandsCharleston$25K
- Laura KinneyCharleston$20K
- Andrew SchreinerCharleston$15K
- Hardik PatelCharleston$15K
- Mithunan MaheswaranathanCharleston$14K
- Frances HughesCharleston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.